BackPear Therapeutics Overview

Pear Therapeutics Long Term Debt

Track Pear Therapeutics's long-term debt ($8.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$8.18M

Peer average

Loading

Pear Therapeutics Long Term Debt History

Loading

Pear Therapeutics vs. peers: Long Term Debt Comparison

Loading

Pear Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Pear Therapeutics (PEAR) FAQ

Pear Therapeutics posts a long-term debt of $8.2M as of December 2022. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Pear Therapeutics's long-term debt was $0. The latest reading is $8.2M (period ending December 2022). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of Pear Therapeutics's financial statement story. At $8.2M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PEAR's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Pear Therapeutics's other metric pages and overview cover the third.